130 related articles for article (PubMed ID: 11363818)
1. ddI plus d4T.
James JS
AIDS Treat News; 1996 Sep; (No 254):4. PubMed ID: 11363818
[TBL] [Abstract][Full Text] [Related]
2. Combining d4T/ddI looks promising.
Posit Aware; 1996; 7(1):7. PubMed ID: 11363129
[TBL] [Abstract][Full Text] [Related]
3. Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.
Rutschmann OT; Opravil M; Iten A; Malinverni R; Vernazza PL; Bucher H; Bernasconi E; Perrin LH; Yerly S; Hirschel B
Antivir Ther; 1998; 3 Suppl 4():65-7. PubMed ID: 10723515
[TBL] [Abstract][Full Text] [Related]
4. d4T plus ddI antiviral results.
AIDS Treat News; 1996 Feb; (no 241):3. PubMed ID: 11363187
[TBL] [Abstract][Full Text] [Related]
5. In vivo antagonism with zidovudine plus stavudine combination therapy.
Havlir DV; Tierney C; Friedland GH; Pollard RB; Smeaton L; Sommadossi JP; Fox L; Kessler H; Fife KH; Richman DD
J Infect Dis; 2000 Jul; 182(1):321-5. PubMed ID: 10882616
[TBL] [Abstract][Full Text] [Related]
6. d4T plus ddI: warning for pregnant women.
AIDS Treat News; 2001 Jan; (358):8. PubMed ID: 12173560
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 Team.
Kline MW; Van Dyke RB; Lindsey JC; Gwynne M; Culnane M; Diaz C; Yogev R; McKinney RE; Abrams EJ; Mofenson LM
Pediatrics; 1999 May; 103(5):e62. PubMed ID: 10224206
[TBL] [Abstract][Full Text] [Related]
8. Back to the nukes.
Smart T
GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
[TBL] [Abstract][Full Text] [Related]
9. [Antiretroviral therapy. Current status and perspectives].
Lüthy R
Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
[No Abstract] [Full Text] [Related]
10. D4T nucleoside combinations for HIV.
Pollard RB
Antiviral Res; 1996 Jan; 29(1):101-4. PubMed ID: 8721558
[No Abstract] [Full Text] [Related]
11. A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients.
Ruxrungtham K; Kroon ED; Ungsedhapand C; Teeratakulpisarn S; Ubolyam S; Buranapraditkun S; van Leeuwen R; Weverling GJ; Kunanusont C; Lange JM; Cooper DA; Phanuphak P
AIDS; 2000 Jul; 14(10):1375-82. PubMed ID: 10930152
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral drug resistance.
Japour AJ
AIDS Clin Care; 1995 Aug; 7(8):63-5, 67. PubMed ID: 11362787
[TBL] [Abstract][Full Text] [Related]
13. FDA triple header. Food and Drug Administration.
Smart T
GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea for HIV?
Treat Rev; 1998; (No 28):10-2. PubMed ID: 11365419
[TBL] [Abstract][Full Text] [Related]
15. What we know about anti-HIV drugs.
Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy increases survival.
Treat Rev; 1995 Nov; (no 20):2-3. PubMed ID: 11363019
[TBL] [Abstract][Full Text] [Related]
17. Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3.
Pollard RB; Peterson D; Hardy D; Pottage J; Murphy RL; Gathe J; Beall G; Rutkievicz V; Reynolds L; Cross AP; Dunkle LM
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):39-48. PubMed ID: 10534145
[TBL] [Abstract][Full Text] [Related]
18. ddI and d4T plus protease inhibitors.
GMHC Treat Issues; 1996 Nov; 10(11):8-9. PubMed ID: 11364012
[TBL] [Abstract][Full Text] [Related]
19. Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James.
Poscher M
AIDS Treat News; 1995 Jul; (no 226):2-4 contd. PubMed ID: 11362613
[TBL] [Abstract][Full Text] [Related]
20. Drug combo safe for HIV-infected children.
NIAID AIDS Agenda; 1996 Sep; ():7. PubMed ID: 11363927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
